Histogen Revenue and Competitors

Location

$76.8M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Histogen's estimated annual revenue is currently $6M per year.(i)
  • 0
  • Histogen's total funding is $76.8M.

Employee Data

    00

Histogen's People

NameTitleEmail/Phone
1
Founder and Scientific AdvisorReveal Email/Phone
2
EVP and CFOReveal Email/Phone
3
VP FinanceReveal Email/Phone
4
Executive Director Clinical AffairsReveal Email/Phone
5
EVP and Chief Scientific OfficerReveal Email/Phone
6
Executive Chairman and Interim President and CEOReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Histogen?

Histogen, Inc. is a regenerative medicine company based on naturally-produced products from newborn fibroblasts grown in a proprietary bioreactor that mimics the embryonic environment. Histogen has developed a rich product portfolio from one core technology process that fulfills market needs without the use of embryonic stem cells or animal products.

keywords:N/A

$76.8M

Total Funding

N/A

Number of Employees

$6M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Histogen News

2022-04-13 - Is Histogen Inc (HSTO) Stock a Smart Investment Wednesday?

Histogen Inc (HSTO) stock is lower by -65.09% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy.

2022-04-13 - Histogen Inc. (NASDAQ:HSTO) Sees Significant Increase in Short ...

Two Sigma Securities LLC lifted its stake in Histogen by 124.7% during the third quarter. Two Sigma Securities LLC now owns 52,289 shares of the...

2022-04-06 - Histogen Up 40% to 35 Cents; Stockholders to Vote on Proposal Related to Reverse Split

Histogen, which received a Nasdaq warning in August related its low bid price, expects the reverse split would help it meet Nasdaq requirements...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$18M0N/A$168.6M
#2
$8.4M0N/AN/A
#3
$11.7M0N/A$4.4M
#4
$36.4M0N/A$778M
#5
$1.7M0N/AN/A